- Home
- / Shandong Buchang Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shandong Buchang Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥16.9
2024-10-29
Market Capitalization
¥18.6 B
2024-10-29
Revenue
¥11.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.4B | 14.0B | 15.7B | 15.5B | 14.7B | 13.0B | 10.8B | 11.7B |
| Cost of goods sold | 2.4B | 2.4B | 3.7B | 4.1B | 4.2B | 4.2B | 4.4B | 4.4B |
| Gross profit | 11.0B | 11.6B | 12.0B | 11.4B | 10.5B | 8.8B | 6.4B | 7.3B |
| Gross profit margin, % | 83.0% | 76.4% | 73.4% | 71.3% | 67.7% | 59.4% | 62.5% | |
| Operating expense total | 8.9B | 9.1B | 9.1B | 9.2B | 8.3B | 7.2B | 5.1B | 5.5B |
| Depreciation and amortization | 372.0M | 384.3M | 643.2M | 502.9M | 3.5B | 1.2B | 1.4B | 728.6M |
| EBITDA | 2.2B | 2.6B | 2.9B | 2.2B | 2.2B | 1.6B | 1.3B | 1.8B |
| EBITDA margin, % | 18.8% | 18.6% | 14.5% | 15.0% | 12.5% | 11.9% | 15.4% | |
| EBIT | 2.3B | 2.5B | 2.5B | 1.8B | (1.3B) | 464.9M | (255.5M) | 651.2M |
| EBIT margin, % | 17.6% | 15.6% | 11.8% | -8.7% | 3.6% | -2.4% | 5.6% | |
| Interest income | 21.2M | 19.1M | 17.3M | 23.7M | 19.9M | 18.8M | 7.5M | 4.8M |
| Interest expense | 91.6M | 136.8M | 145.0M | 167.3M | 135.1M | 109.9M | 129.6M | 118.7M |
| Pre tax profit | 2.3B | 2.4B | 2.4B | 1.7B | (1.4B) | 394.6M | (365.3M) | 534.0M |
| Income tax expense | 347.1M | 451.5M | 517.6M | 478.3M | 331.6M | 242.7M | 337.1M | 341.7M |
| Net Income | 1.9B | 2.0B | 1.8B | 1.2B | (1.7B) | 151.9M | (702.4M) | 192.3M |